SB 24-060 CO Introduced
Prescription Drug Affordability Board Exempt Orphan Drugs
A state bill is a proposed law in a state legislature — separate from the U.S. Congress. Learn more →
Summary
The bill states that the Colorado prescription drug affordability review board has no authority to perform an affordability review of, or to establish an upper payment limit for, any prescription drug that is designated as a drug for a rare disease or condition by the federal food and drug administration. (Note: This summary applies to this bill as introduced.)
Sponsors (3)
- Barbara Kirkmeyer Republican · primary
- Joann Ginal · primary
- Anthony Hartsook Republican · primary
Action history (9)
- Apr 15, 2024 Senate Second Reading Laid Over to 05/09/2024 - No Amendments · upper
- Apr 8, 2024 Senate Second Reading Laid Over to 04/15/2024 - No Amendments · upper
- Apr 2, 2024 Senate Second Reading Laid Over to 04/08/2024 - No Amendments · upper
- Apr 1, 2024 Senate Second Reading Laid Over Daily - No Amendments · upper
- Mar 18, 2024 Senate Second Reading Laid Over to 04/01/2024 - No Amendments · upper
- Mar 11, 2024 Senate Second Reading Laid Over to 03/18/2024 - No Amendments · upper
- Feb 27, 2024 Senate Second Reading Laid Over to 03/11/2024 - No Amendments · upper
- Feb 22, 2024 Senate Committee on State, Veterans, & Military Affairs Refer Unamended to Senate Committee of the Whole · upper
- Jan 19, 2024 Introduced In Senate - Assigned to State, Veterans, & Military Affairs · upper
Full text
The full text hasn’t been imported yet. CivicGate fetches it from the state legislature’s published version documents — check now.
Comments
Data from OpenStates. View on OpenStates →
Comments